Body mass index and circulating oestrone sulphate in women treated with adjuvant letrozole.
about
Prognostic impact of progesterone receptor status combined with body mass index in breast cancer patients treated with adjuvant aromatase inhibitor.Postmenopausal Breast Cancer, Aromatase Inhibitors, and Bone Health: What the Surgeon Should Know.Body mass index and aromatase inhibitors: a step forward in individualizing therapy for breast cancer patients?Effects of exemestane and letrozole therapy on plasma concentrations of estrogens in a randomized trial of postmenopausal women with breast cancer.Obesity and survival in the neoadjuvant breast cancer setting: role of tumor subtype in an ethnically diverse population.
P2860
Body mass index and circulating oestrone sulphate in women treated with adjuvant letrozole.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 21 January 2014
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Body mass index and circulatin ...... eated with adjuvant letrozole.
@en
Body mass index and circulatin ...... eated with adjuvant letrozole.
@nl
type
label
Body mass index and circulatin ...... eated with adjuvant letrozole.
@en
Body mass index and circulatin ...... eated with adjuvant letrozole.
@nl
prefLabel
Body mass index and circulatin ...... eated with adjuvant letrozole.
@en
Body mass index and circulatin ...... eated with adjuvant letrozole.
@nl
P2093
P2860
P50
P356
P1476
Body mass index and circulatin ...... eated with adjuvant letrozole.
@en
P2093
M Mansutti
M Porpiglia
P2860
P2888
P304
P356
10.1038/BJC.2014.2
P407
P577
2014-01-21T00:00:00Z
P5875
P6179
1005035290